HeartBeam, Inc.(BEAT)

Medical - Specialties · Santa Clara, CA

$0.60-0.06 (-8.42%)

Delayed quote: Oct 6, 2026, 1:30 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T17:30:45.067Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:30:45.067Z.

Quote observation: 2026-10-06T17:30:05.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 33,254,145
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 8,722,000
TTM operating EBITDA · period ending 2026-06-30: -20,302,000

FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BEAT EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

BEAT Competitors' EV/EBITDA Ratio

BEAT

HeartBeam, Inc.

Current

Market Cap

$33.25M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs BEAT

Market Cap

$33.17M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BEAT

Market Cap

$32.92M

EV/EBITDA Ratio

N/A

TTM Avg

10986.66x

3Y Avg

10986.66x

5Y Avg

10986.66x

SCLX

Scilex Holding Company

vs BEAT

Market Cap

$33.71M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs BEAT

Market Cap

$33.32M

EV/EBITDA Ratio

N/A

TTM Avg

25.79x

3Y Avg

51.85x

5Y Avg

38.84x

RMTI

Rockwell Medical, Inc.

vs BEAT

Market Cap

$32.68M

EV/EBITDA Ratio

N/A

TTM Avg

26.23x

3Y Avg

26.23x

5Y Avg

26.23x

ELUT

Elutia Inc

vs BEAT

Market Cap

$34.04M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BEAT

Market Cap

$34.66M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSYS

Nortech Systems Incorporated

vs BEAT

Market Cap

$31.44M

EV/EBITDA Ratio

12.82x

TTM Avg

114.94x

3Y Avg

46.61x

5Y Avg

32.69x

BDMD

Baird Medical Investment Holdings Limited

vs BEAT

Market Cap

$31.58M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
HeartBeam, Inc. (BEAT)	$33.25M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.17M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.92M	N/A	10986.66x	10986.66x	10986.66x
Scilex Holding Company (SCLX)vs ›	$33.71M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$33.32M	N/A	25.79x	51.85x	38.84x
Rockwell Medical, Inc. (RMTI)vs ›	$32.68M	N/A	26.23x	26.23x	26.23x
Elutia Inc (ELUT)vs ›	$34.04M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$34.66M	N/A	N/A	N/A	N/A
Nortech Systems Incorporated (NSYS)vs ›	$31.44M	12.82x	114.94x	46.61x	32.69x
Baird Medical Investment Holdings Limited (BDMD)vs ›	$31.58M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics